LEUKOTRIENE RECEPTOR ANTAGONISTS
Tracking # 20-1057720
$99999.00
There are no ratings for this course
Learn more Educator STATPEARLS PUBLISHING, LLC
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
MONTELUKAST AND ZAFIRLUKAST ARE CYSTEINYL LEUKOTRIENE RECEPTOR ANTAGONISTS INDICATED TO PREVENT AND TREAT CHRONIC ASTHMA. LEUKOTRIENES ARE EICOSANOID INFLAMMATORY MEDIATORS DERIVED FROM ARACHIDONIC ACID. NEITHER MONTELUKAST NOR ZAFIRLUKAST HAS A ROLE AS RESCUE MEDICATION DURING AN ACUTE ASTHMATIC ATTACK. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND MONITORING PERTINENT FOR INTERPROFESSIONAL TEAM MEMBERS IN MANAGING PATIENTS WITH ASTHMA AND RELATED CONDITIONS WITH LEUKOTRIENE RECEPTOR ANTAGONISTS.
Subject areas
This course counts toward the state boards and subject areas below.
Bahamas Medical Council
Specialty Medical Practitioner
1h
General Medicine
Louisiana State Board of Medical Examiners - Physicians & Surgeons
Physician & Surgeon
1h
Category I CME
Mississippi State Board of Medical Licensure
Medical Doctor
1h
AMA Category I
Physician Assistant
1h
AMA Category I
State Medical Board of Ohio
Doctor of Medicine
1h
AMA Category I